Moneycontrol PRO
HomeNewsBusinessRBI relaxes overdraft facility stipulations for states, UTs

RBI relaxes overdraft facility stipulations for states, UTs

The RBI said this will “provide greater flexibility to the state governments to tide over their cashflow mismatches”

April 08, 2020 / 14:36 IST

The Reserve Bank of India (RBI) has permitted state governments and union territories (UTs) greater flexibility for availing overdraft facilities with immediate effect till September 30.

In a statement issued on April 7, the central bank said it had decided after a review to increase it to 21 working days, the period for which a state or UT could be in overdraft continuously. The previous stipulation was of 14 working days.

Follow our LIVE Updates on the coronavirus pandemic here

The number of days a state or UT can be in overdraft in a quarter has also been increased to 50 working days from the current stipulation of 36 working days.

All other stipulations remain the same. The RBI said this would “provide greater flexibility to the state governments to tide over their cash flow mismatches”.

COVID-19 Vaccine

Frequently Asked Questions

View more
How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

View more
Show

This comes after the RBI, on April 1, announced a series or additional measures for dealing with the coronavirus pandemic.

In a statement on the RBI website, the central bank said it had extended the realisation period of export proceeds, reviewed limits of ways and means advances (WMA) to states and union territories (UTs), and put in place a framework for implementation of countercyclical capital buffer (CCyB).

Earlier on March 27, RBI Governor Shaktikanta Das announced a massive 75-basis-point cut in repo rates as a measure to counter the economic slowdown caused by the COVID-19 pandemic. The reverse repo rate was cut by 90 basis points to 4 percent. Das said this as well as a host of other measures injecting Rs 3 lakh crore into the economy, had been done to make it unattractive for banks to passively deposit funds with the RBI and instead lend it to the productive sectors.

Follow our full COVID-19 coverage here

Moneycontrol News
first published: Apr 8, 2020 02:35 pm

Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!

Subscribe to Tech Newsletters

  • On Saturdays

    Find the best of Al News in one place, specially curated for you every weekend.

  • Daily-Weekdays

    Stay on top of the latest tech trends and biggest startup news.

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347